Epitalon is one of the few things here described as a short course rather than a standing dose. NAD+ continues past it. The stop is the point.
Shared by
quietlifter
Metabolic and longevity compounds, mostly. Interested in what the trials actually measured.
- 2 stacks published
- Tracking since 3 Sept 2026
Published stacks
MOTS-c and NAD+ get combined on the reasoning that one signals mitochondrial stress and the other supplies the coenzyme. That reasoning is plausible and untested in combination.
Elsewhere
More like this
- Every shared stackStacks other people have published, alongside combinations we have written up and cited.
- What the research saysProfiles for every compound above — what is studied, at what dose, and how strong the evidence is.
- Keep your own recordLog doses against the vial they came from. Private unless you choose otherwise, like this page.
Report this
Shared by a Bioalmanac user, not written or checked by us. It describes what one person did, which is not evidence and not advice. This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice.